1. Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
   Nikolaos A. Dallas et al, 2008, Clinical Cancer Research CrossRef
2. Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma
   Mariam Oladejo et al, 2022, Frontiers in Immunology CrossRef